(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDELIS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MEDELIS

ST13

US500000078525674

Class

35, 42

Filing

78525674

Registration

3111325

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

02/13/2026

Trademark type

Word

Nice classes

35, 42

Filing date

12/02/2004

Registration date

07/04/2006

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/21/2016

Last transaction

02/13/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

12/15/2003

First use in commerce

12/15/2003

Drawing code

4

Owner type

03

Owner location

Costa Mesa, CA

Examiner

KAZAZIAN, MICHAEL H

Law office

M40

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Medelis, Inc.
Medelis, Inc.

Representatives

Susan Stone Rosenfield FENNEMORE CRAIG, P.C.

Technical classification

Nice Classes

Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Biostatistical design and database managementdata processing and collection; Medical and pharmaceutical consultation in the nature of auditingstaffing and patient recruiting for clinical treatment sites; Pharmaceutical product managementpackaginglabelinginventory control and recovery services

Class 42

Medical and scientific research; medical and scientific researchnamely conducting clinical trials; Pharmaceutical research and development services; pharmaceutical product evaluation; Clinical development plan design and consulting; Consultation in the field of new drug applications and regulatory matters; Pharmaceutical and medical protocol writing; Pharmaceutical and regulatory report preparation and submission; Quality control services for others

Publications

History of USPTO decisions and trademark events.

25 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/04/2025

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/21/2016

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/21/2016

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/21/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/21/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

06/30/2016

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/04/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/29/2014

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/06/2012

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/06/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/06/2012

E815

TEAS SECTION 8 & 15 RECEIVED

05/25/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

07/04/2006

PUBO

PUBLISHED FOR OPPOSITION

04/11/2006

NPUB

NOTICE OF PUBLICATION

03/22/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/22/2006

ALIE

ASSIGNED TO LIE

02/21/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/02/2006

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/27/2006

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/11/2006

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/11/2006

GNRT

NON-FINAL ACTION E-MAILED

07/14/2005

CNRT

NON-FINAL ACTION WRITTEN

07/14/2005

DOCK

ASSIGNED TO EXAMINER

07/07/2005

NWAP

NEW APPLICATION ENTERED

12/10/2004

Continuous trademark protection

Get notified about every new filing that threatens MEDELIS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.